Astal Lab

{
  "main_header": {
    "sid": 157295,
    "name": "Astal Lab",
    "stock_name": "Astal Lab",
    "full_name": "Astal Laboratories Ltd",
    "name_url": "stocks-analysis/astal-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "88.84",
    "chg": 14.63,
    "chgp": "19.71%",
    "dir": 1,
    "prev_price": "74.21",
    "mcapval": "348.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 512600,
    "symbol": "",
    "ind_name": "Trading & Distributors",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE307N01014",
    "curr_date": "May 08",
    "curr_time": "",
    "bse_nse_vol": "1.31 lacs",
    "exc_status": "Active",
    "traded_date": "May 08, 2026",
    "traded_date_str": "2026 05 08",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astal-lab-157295-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Astal Laboratories Ltd Valuation Shifts Amid Market Rally",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-valuation-shifts-amid-market-rally-3980554",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstalLaboratori_valuationdot_3980554.png",
        "date": "2026-05-08 08:00:04",
        "description": "Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating. This change comes amid a strong day gain of 17.61% and a mixed performance relative to the Sensex over various time frames, prompting a detailed analysis of its price attractiveness and comparative metrics."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-sell-3975849",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/AstalLaboratori_mojoScore_3975849.png",
        "date": "2026-05-05 10:10:02",
        "description": "Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Astal Laboratories Ltd Falls to 52-Week Low of Rs 61 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-stock-hits-52-week-low-at-rs61-3964550",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_priceRelatedfactors_3964550.png",
        "date": "2026-04-27 13:35:05",
        "description": "For the third consecutive session, Astal Laboratories Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 61 on 27 Apr 2026. This marks a significant 40.8% drop from its 52-week high of Rs 103.2, underscoring persistent selling pressure despite some positive financial indicators."
      },
      {
        "title": "Astal Laboratories Ltd Falls to 52-Week Low of Rs 62.49 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-stock-hits-52-week-low-at-rs6249-3960908",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_priceRelatedfactors_3960908.png",
        "date": "2026-04-24 12:35:05",
        "description": "For the second consecutive session, Astal Laboratories Ltd has closed lower, slipping to a fresh 52-week low of Rs 62.49 on 24 Apr 2026, extending its year-long decline despite some encouraging financial metrics."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-sell-3960722",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_mojoScore_3960722.png",
        "date": "2026-04-24 10:10:03",
        "description": "Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astal Laboratories Ltd Falls to 52-Week Low of Rs 63 as Sell-Off Deepens",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-falls-to-52-week-low-of-rs63-amid-market-divergence-3956017",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_priceRelatedfactors_3956017.png",
        "date": "2026-04-21 11:40:10",
        "description": ""
      },
      {
        "title": "Astal Laboratories Ltd: Valuation Shift Signals Price Attractiveness Amid Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astal-laboratories-ltd-valuation-shift-signals-price-attractiveness-amid-market-challenges-3946372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_valuationdot_3946372.png",
        "date": "2026-04-15 08:00:14",
        "description": "Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has seen its valuation parameters shift notably, moving from a very expensive to an expensive rating. This change reflects a subtle but significant deterioration in price attractiveness, driven by a combination of elevated price-to-earnings and price-to-book ratios relative to historical and peer benchmarks. Investors face a challenging landscape as the stock underperforms broader indices and peers, prompting a reassessment of its investment appeal."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-sell-3944678",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_mojoScore_3944678.png",
        "date": "2026-04-13 10:10:14",
        "description": "Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "Astal Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astal-laboratories-ltd-is-rated-sell-3930253",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/AstalLaboratori_mojoScore_3930253.png",
        "date": "2026-04-02 10:10:16",
        "description": "Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      }
    ],
    "total": 143,
    "sid": "157295",
    "stock_news_url": "https://www.marketsmojo.com/news/astal-laboratories-157295"
  },
  "announcements": [
    {
      "caption": "Intimation Under Regulation 30 (LODR) 2015- Website",
      "datetime": "30-Apr-2026",
      "details": "Submission of website intimation.",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "27-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Astal Laboratories Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L74120UP1993PLC015605</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>11.80</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: Mahendra Kumar <br/> Designation: Company Secretary and Compliance Officer <br/> EmailId: csmahendra07@gmail.com</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: Balayogiswara Rao Peddinti <br/> Designation: CFO <br/> EmailId: balu@astallabs.com</div> </div> <div> <br/> Date: 27/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "09-Apr-2026",
      "details": "Submission of certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astal Laboratories Ltd Valuation Shifts Amid Market Rally

2026-05-08 08:00:04

Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a significant shift in its valuation parameters, moving from an expensive to a very expensive rating. This change comes amid a strong day gain of 17.61% and a mixed performance relative to the Sensex over various time frames, prompting a detailed analysis of its price attractiveness and comparative metrics.

Read full news article

Astal Laboratories Ltd is Rated Sell

2026-05-05 10:10:02

Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 May 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

Astal Laboratories Ltd Falls to 52-Week Low of Rs 61 as Sell-Off Deepens

2026-04-27 13:35:05

For the third consecutive session, Astal Laboratories Ltd has seen its share price decline, culminating in a fresh 52-week low of Rs 61 on 27 Apr 2026. This marks a significant 40.8% drop from its 52-week high of Rs 103.2, underscoring persistent selling pressure despite some positive financial indicators.

Read full news article

Astal Laboratories Ltd Falls to 52-Week Low of Rs 62.49 as Sell-Off Deepens

2026-04-24 12:35:05

For the second consecutive session, Astal Laboratories Ltd has closed lower, slipping to a fresh 52-week low of Rs 62.49 on 24 Apr 2026, extending its year-long decline despite some encouraging financial metrics.

Read full news article

Astal Laboratories Ltd is Rated Sell

2026-04-24 10:10:03

Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 24 April 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Astal Laboratories Ltd Falls to 52-Week Low of Rs 63 as Sell-Off Deepens

2026-04-21 11:40:10

Read full news article

Astal Laboratories Ltd: Valuation Shift Signals Price Attractiveness Amid Market Challenges

2026-04-15 08:00:14

Astal Laboratories Ltd, a micro-cap player in the Trading & Distributors sector, has seen its valuation parameters shift notably, moving from a very expensive to an expensive rating. This change reflects a subtle but significant deterioration in price attractiveness, driven by a combination of elevated price-to-earnings and price-to-book ratios relative to historical and peer benchmarks. Investors face a challenging landscape as the stock underperforms broader indices and peers, prompting a reassessment of its investment appeal.

Read full news article

Astal Laboratories Ltd is Rated Sell

2026-04-13 10:10:14

Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 13 April 2026, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

Astal Laboratories Ltd is Rated Sell

2026-04-02 10:10:16

Astal Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 02 April 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

View All News